Showing 49–60 of 68 results

Cetuximab

273,00 

Therapeutic EGFR-antibody from the original Erbitux commercial drug targeting the EGFR-antigen, also referred to as Erbitux antibody.

Ipilimumab

961,00 

Therapeutic CTLA4-antibody from the original commercial drug Yervoy targeting the CTLA4-antigen (CD152), also referred to as Iplimumab antibody. This antibody is available with the original certificate of analysis (CoA).

Pertuzumab

633,00 

Therapeutic HER2-antibody from the original commercial drug Perjeta targeting the HER2-antigen, also referred to as Pertuzumab antibody. This antibody is available with the original certificate of analysis (CoA).

Durvalumab

197,00 

Therapeutic PD-L1-antibody from the original commercial drug Imfinzi targeting the PD-L1-antigen, also referred to as Durvalumab antibody.

Avelumab

301,00 

Therapeutic PD-L1-antibody from the original commercial drug Bavencio targeting the PD-L1-antigen, also referred to as Avelumab antibody.

Nivolumab

299,00 

Therapeutic PD-1-antibody from the original Opdivo commercial drug targeting the PD-1-antigen, also referred to as Opdivo antibody.

Infliximab

355,00 

Therapeutic TNF-α-antibody from the original Remicade commercial drug targeting the TNF-α-antigen, also referred to as Remicade antibody.

Golimumab

628,00 

Therapeutic TNF-α-antibody from the original Simponi commercial drug targeting the TNF-α-antigen, also referred to as Simponi antibody.

Tocilizumab

126,00 

Therapeutic IL-6 R-antibody from the original RoActemra commercial drug targeting the IL-6 R-antigen, also referred to as RoActemra antibody.

Denosumab

172,00 

Therapeutic RANKL-antibody from the original Prolia commercial drug targeting the RANKL-antigen, also referred to as Prolia antibody.

Ustekinumab

1.267,00 

Therapeutic IL-12-antibody from the original Stelara commercial drug targeting the IL-12-antigen, also referred to as Stelara antibody.